je.st
news
Valuing Gilead Sciences Based On Free Cash Flow Projections
2016-03-08 21:07:01| Biotech - Topix.net
I anticipate that the company will continue to maintain its competitive advantage for HIV and Hepatitis C products. However, regulatory pressure on pricing remains less certain.
Tags: free
based
cash
flow
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||